Iterum Therapeutics
ITRM
ITRM was delisted on the 31st of March, 2026.
22 hedge funds and large institutions have $198K invested in Iterum Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.71% less ownership
Funds ownership: 2.6% → 1.89% (-0.71%)
12% less funds holding
Funds holding: 25 → 22 (-3)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
66% less capital invested
Capital invested by funds: $575K → $198K (-$378K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$33K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.88K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.38K |
| 4 |
Renaissance Technologies
New York
|
+$3.41K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$142 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$49K |
| 2 |
GC
Grimes & Company
Westborough,
Massachusetts
|
-$24K |
| 3 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$11K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$7.97K |
| 5 |
Morgan Stanley
New York
|
-$1.65K |
ITRM Hedge Fund Activity: Q4 2022 in Review
22 institutional investors reported a position in Iterum Therapeutics (ITRM) for Q4 2022, worth a combined $198K — down 66% from $575K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ITRM and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $33K. The largest seller was Jane Street, exiting entirely with an estimated $49K sold.
- 22 institutional investors held Iterum Therapeutics (ITRM) as of Q4 2022, down from 25 in Q3 2022.
- Funds reported $198K of Iterum Therapeutics stock for Q4 2022, down 66% quarter-over-quarter.
- 3 funds opened new Iterum Therapeutics positions in Q4 2022 and 4 closed out, a net change of -1 holder.
- The largest Iterum Therapeutics buyer in Q4 2022 was Virtu Financial, an estimated $33K added.
- The largest Iterum Therapeutics seller in Q4 2022 was Jane Street, an estimated $49K sold.
Based on aggregated 13F filings for Q4 2022.